Topical provocation in 31 cases of fixed drug eruption: Change of causative drugs in 10 years

Contact Dermatitis

Volumn 38, Issue 5, 1998, Pages 258-260

  Lee, Ai Young ^a  

^a Eulji General Hospital   (South Korea)

Author keywords

Chlormezanone; Drug reactions; Fixed drug eruption; Infiltration; Lesional patch test; Medicaments; Patch testing technique; Positive patch test; Sulfamethoxazole trimethoprim

Indexed keywords

ANXIOLYTIC AGENT; CHLORMEZANONE; COTRIMOXAZOLE; SULFONAMIDE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; DIAGNOSTIC VALUE; DRUG ERUPTION; FEMALE; HUMAN; MALE; PATCH TEST; PROVOCATION TEST; SCHOOL CHILD;

ADOLESCENT; ADULT; CHILD; DRUG ERUPTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PATCH TESTS;

EID: 0031799710     PISSN: 01051873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0536.1998.tb05739.x     Document Type: Article

References (16)

1. Alanko K, Stubb S, Reitamo S. Topical provocation of fixed drug eruption. Br J Dermatol 1987: 116: 561-567.
2. Stritzler C, Kopf A W. Fixed drug eruption caused by 8-chlorothephylline in dramamine with clinical and histologic studies. J Invest Dermatol 1960: 34: 319-330.
3. Guin J D, Haynie L S, Jackson D, Baker G F. Wandering fixed drug erupt on: a mucocutaneous reaction to acetaminophen. J Am Acad Dermatol 1987: 17: 399-402.
4. Lee A Y, Lee Y S. Diagnostic value of patch test in fixed drug eruption. Allergy 1989: 9: 460-465 (in Korean).
5. Lee A Y, Lee Y S. Provocation tests in a chlormezanone-induced fixed drug eruption. DICP 1991: 25: 604-605.
6. Fujimoto Y, Hayakawa R, Suzuki M, Ogino Y. Fixed drug eruption due to allylisopropylacetylurea. Contact Dermatitis 1993: 28: 282-284.
7. Oleaga J M, Auuirre A, Gonzalez, Diaz-Perez J L. Topical provocation of fixed drug eruption due to sulphamethoxazole. Contact Dermatitis 1993: 29: 155-167.
8. Alanko K. Patch testing in cutaneous reactions caused by carbamazepine. Contact Dermatitis 1993: 29: 254-257.
9. Alanko K. Topical provocation of fixed drug eruption. A study of 30 patients. Contact Dermatitis 1994: 31: 25-27.
10. Spielberg S P. In vitro assessment of pharmacogenetic susceptability to toxic drug metabolites in humans. Fed Proc 1984: 43: 2308-2313.
11. Cribb A E, Spielberg S P. Sulfamethoxazole is metabolized to the hydroxylamine in humans. Clin Pharmacol Ther 1992: 51: 522-526.
12. Cribb A E, Miller M, Tesoro A, Spielberg S P. Peroxidase-dependent oxidation of sulfonamides by monocytes and neutrophils from humans and dogs. Mol Pharmacol 1990: 38: 744-751.
13. Pasricha J S. Drugs causing fixed eruptions. Br J Dermatol 1979: 700: 183-185.
14. Kauppinen K, Stubb S. Fixed eruptions: causative drugs and challenge tests. Br J Dermatol 1985: 112: 575-578.
15. Sehgal V N, Grangwani O P. Fixed drug eruptions: a study of epidemiological, clinical and diagnostic aspects of 89 cases from India. J Dermatol 1988: 15: 50-54.
16. Thankappan T P, Zachariah J. Drug-specific clinical pattern in fixed drug eruptions. Int J Dermatol 1991: 30: 867-870.